Confirmed Control Closed Transaction verified BeautyClinical SkincareCPGSkincare
Obagi acquired by Waldencast
Waldencast acquired Obagi, a skincare brand on Nov 15, 2021. FundComb records estimated consideration of EUR 756m. The current comp implies EV / revenue of 4.5x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Obagi
- Acquirer
- Waldencast
- Seller
- -
- Announced
- 2021-11-15
- Geography
- -
- Tags
- BeautyClinical SkincareCPGSkincare
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-18
- Latest update
- 2026-07-13
Value and multiples
Price / value
EUR 756M
Transaction value | EUR
Basis: FundComb estimate
Approx. $865M USD using FX date 2021-11-15 at 1.1444 EUR/USD.
EV / revenue
4.5x
Period not stated
Basis: FundComb estimate
EV / EBITDA
17.2x
EBITDA basis not stated
Basis: FundComb estimate
Basis
- EUR 756m transaction value is a FundComb estimate. Public sources reviewed confirm the transaction, but do not independently disclose every valuation input.
- Implied EV / revenue is 4.5x, calculated from EUR 756m value and EUR 168m revenue.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- Implied EV / EBITDA is 17.2x, calculated from EUR 756m value and EUR 44.0m EBITDA.
Source summary
No public source summary has been published for this transaction yet.